Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Fitzmaurice

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Eclinicalmedicine|January 1, 2020
Patients with high levels of circulating endothelial progenitor cells (EPC) following at least three months of anticoagulation for unprovoked venous thromboembolism (VTE) are at low risk of recurrent VTE-Results from the ExACT randomised controlled trialCharlotte Bradbury, Tracey Buckley, Yong Zhong Sun, et al.
The European Respiratory Journal|June 24, 2017
Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD scoreShamil Haroon, Peymane Adab, Richard D Riley, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 17, 2015
Cohort study of Anticoagulation Self-Monitoring (CASM): a prospective study of its effectiveness in the communityAlison Ward, Alice Tompson, David Fitzmaurice, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 17, 2015
Supporting patients to self-monitor their oral anticoagulation therapy: recommendations based on a qualitative study of patients' experiencesAlice Tompson, Carl Heneghan, David Fitzmaurice, et al.
Journal of Thrombosis and Thrombolysis|May 10, 2006
What are the barriers to warfarin use in atrial fibrillation?: Development of a questionnaireAnders Ingelgård, Jennifer Hollowell, Prabashni Reddy, et al.
BMC Medical Research Methodology|May 4, 2007
Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetesCarl Heneghan, Rafael Perera, Alison Ward A, et al.
Qualitative Health Research|December 4, 2018
The Push and Pull of Self-Managing Mild COPD: An Evaluation of Participant Experiences of a Nurse-Led Telephone Health Coaching InterventionPeter A Coventry, Amy Blakemore, Elizabeth Baker, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 18, 2017
Incidence of venous thromboembolism in care homes: a prospective cohort studyPatricia N Apenteng, Fd Richard Hobbs, Andrea Roalfe, et al.
BMJ Open|April 4, 2013
ExPeKT--Exploring prevention and knowledge of venous thromboembolism: a two-stage, mixed-method study protocolLorraine McFarland, Alison Ward, Sheila Greenfield, et al.
BJGP Open|December 20, 2018
Non-vitamin k antagonist oral anticoagulants in a European primary care physician surveyClaudio Cimminiello, Robert Hatala, Sami Pakarinen, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Eclinicalmedicine|January 1, 2020
Patients with high levels of circulating endothelial progenitor cells (EPC) following at least three months of anticoagulation for unprovoked venous thromboembolism (VTE) are at low risk of recurrent VTE-Results from the ExACT randomised controlled trialCharlotte Bradbury, Tracey Buckley, Yong Zhong Sun, et al.
The European Respiratory Journal|June 24, 2017
Predicting risk of undiagnosed COPD: development and validation of the TargetCOPD scoreShamil Haroon, Peymane Adab, Richard D Riley, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 17, 2015
Cohort study of Anticoagulation Self-Monitoring (CASM): a prospective study of its effectiveness in the communityAlison Ward, Alice Tompson, David Fitzmaurice, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|June 17, 2015
Supporting patients to self-monitor their oral anticoagulation therapy: recommendations based on a qualitative study of patients' experiencesAlice Tompson, Carl Heneghan, David Fitzmaurice, et al.
Journal of Thrombosis and Thrombolysis|May 10, 2006
What are the barriers to warfarin use in atrial fibrillation?: Development of a questionnaireAnders Ingelgård, Jennifer Hollowell, Prabashni Reddy, et al.
BMC Medical Research Methodology|May 4, 2007
Assessing differential attrition in clinical trials: self-monitoring of oral anticoagulation and type II diabetesCarl Heneghan, Rafael Perera, Alison Ward A, et al.
Qualitative Health Research|December 4, 2018
The Push and Pull of Self-Managing Mild COPD: An Evaluation of Participant Experiences of a Nurse-Led Telephone Health Coaching InterventionPeter A Coventry, Amy Blakemore, Elizabeth Baker, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|January 18, 2017
Incidence of venous thromboembolism in care homes: a prospective cohort studyPatricia N Apenteng, Fd Richard Hobbs, Andrea Roalfe, et al.
BMJ Open|April 4, 2013
ExPeKT--Exploring prevention and knowledge of venous thromboembolism: a two-stage, mixed-method study protocolLorraine McFarland, Alison Ward, Sheila Greenfield, et al.
BJGP Open|December 20, 2018
Non-vitamin k antagonist oral anticoagulants in a European primary care physician surveyClaudio Cimminiello, Robert Hatala, Sami Pakarinen, et al.
Pageof 8